Integrated Analysis of Hematopoietic Differentiation Outcomes and Molecular Characterization Reveals Unbiased Differentiation Capacity and Minor Transcriptional Memory in HPC/HSC-iPSCs
Overview
Affiliations
Background: Transcription factor-mediated reprogramming can reset the epigenetics of somatic cells into a pluripotency compatible state. Recent studies show that induced pluripotent stem cells (iPSCs) always inherit starting cell-specific characteristics, called epigenetic memory, which may be advantageous, as directed differentiation into specific cell types is still challenging; however, it also may be unpredictable when uncontrollable differentiation occurs. In consideration of biosafety in disease modeling and personalized medicine, the availability of high-quality iPSCs which lack a biased differentiation capacity and somatic memory could be indispensable.
Methods: Herein, we evaluate the hematopoietic differentiation capacity and somatic memory state of hematopoietic progenitor and stem cell (HPC/HSC)-derived-iPSCs (HPC/HSC-iPSCs) using a previously established sequential reprogramming system.
Results: We found that HPC/HSCs are amenable to being reprogrammed into iPSCs with unbiased differentiation capacity to hematopoietic progenitors and mature hematopoietic cells. Genome-wide analyses revealed that no global epigenetic memory was detectable in HPC/HSC-iPSCs, but only a minor transcriptional memory of HPC/HSCs existed in a specific tetraploid complementation (4 N)-incompetent HPC/HSC-iPSC line. However, the observed minor transcriptional memory had no influence on the hematopoietic differentiation capacity, indicating the reprogramming of the HPC/HSCs was nearly complete. Further analysis revealed the correlation of minor transcriptional memory with the aberrant distribution of H3K27me3.
Conclusions: This work provides a comprehensive framework for obtaining high-quality iPSCs from HPC/HSCs with unbiased hematopoietic differentiation capacity and minor transcriptional memory.
Yang Y, Ma B, Chen J, Liu D, Ma J, Li B Clin Epigenetics. 2024; 16(1):30.
PMID: 38383473 PMC: 10880347. DOI: 10.1186/s13148-024-01639-5.
Blumke A, Ijeoma E, Simon J, Wellington R, Purwaningrum M, Doulatov S Stem Cell Res Ther. 2023; 14(1):319.
PMID: 37936199 PMC: 10631132. DOI: 10.1186/s13287-023-03547-6.
Blumke A, Ijeoma E, Simon J, Wellington R, Purwaningrum M, Doulatov S Res Sq. 2023; .
PMID: 37461708 PMC: 10350192. DOI: 10.21203/rs.3.rs-3089289/v1.
A circular RNA map for human induced pluripotent stem cells of foetal origin.
Barilani M, Cherubini A, Peli V, Polveraccio F, Bollati V, Guffanti F EBioMedicine. 2020; 57:102848.
PMID: 32574961 PMC: 7322262. DOI: 10.1016/j.ebiom.2020.102848.